Recent times have witnessed an upsurge in the incidence of neurodegenerative disorders
such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and …

Introduction It is now accepted that Parkinson's disease (PD) is not simply due to
dopaminergic dysfunction, and there is interest in developing non-dopaminergic …

Controlled release is of vital relevance for many drugs; thus, there is a keen interest in
materials that can improve the release profiles of formulations administered via buccal …

Parkinson's disease (PD) is a devastating neurodegenerative disorder predominantly
affecting the elderly, characterized by the loss of dopaminergic neurons in the substantia …

Tardive dyskinesia (TD) is a heterogeneous syndrome of involuntary hyperkinetic
movements that is often persistent and occurs belatedly during treatment with antipsychotics …

We conducted an updated systematic review on the safety and efficacy of amantadine in
cognitive recovery after traumatic brain injury (TBI), in order to determine if the current …

Abstract Development of motor fluctuations and dyskinesia characterizes the transition from
early to advanced Parkinson disease stage. Current therapeutic strategies to manage motor …

Parkinson's disease (PD) is a progressive, neurodegenerative movement disorder caused
by loss of nigrostriatal dopamine (DA) neurons. DA replacement therapy using L-3, 4 …

The aging of human populations, including those in Europe, is an indisputable fact. The
challenge for the future is not simply prolonging human life at any cost or by any means but …

Background Huntington's disease is an autosomal dominant inherited disorder
characterized by personality changes (such as irritability and restlessness) and psychotic …